Paper Details
- Home
- Paper Details
Novel treatment options in platinum-sensitive recurrent ovarian cancer: A review.
Author: KurokiLindsay M, MullenMary M, ThakerPremal H
Original Abstract of the Article :
Epithelial ovarian cancer (EOC) is the leading cause of death due to gynecologic malignancy. The majority of advanced stage EOC patients, even those who respond well to frontline therapy, will ultimately recur and succumb to their disease. In platinum-sensitive EOC patients, or those who recur ≥6 mo...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1016/j.ygyno.2018.10.023
データ提供：米国国立医学図書館（NLM）
New Treatment Options for Platinum-Sensitive Recurrent Ovarian Cancer: A Review
This review explores novel treatment options for platinum-sensitive recurrent ovarian cancer, a challenging condition that affects many women. The authors examine the evolving landscape of treatment strategies, focusing on the role of platinum-based chemotherapy, anti-angiogenesis therapeutics, and poly-ADP-ribose polymerase (PARP) inhibitors. The review highlights the significant advancements in targeted therapies and the increasing focus on personalized treatment approaches. This research provides a comprehensive overview of current treatment options for recurrent ovarian cancer, offering hope for improved outcomes and a better quality of life for patients.
Targeted Therapies: A New Era of Treatment for Recurrent Ovarian Cancer
This review highlights the emergence of targeted therapies for platinum-sensitive recurrent ovarian cancer. The authors discuss the growing role of anti-angiogenesis therapeutics and PARP inhibitors, demonstrating the shift towards a more personalized approach to treatment. This research offers hope for improved outcomes and a better quality of life for patients with this challenging condition.
Personalized Treatment Approaches: Optimizing Outcomes for Ovarian Cancer Patients
This review emphasizes the importance of personalized treatment approaches for patients with recurrent ovarian cancer. The authors discuss the need for tailored therapies based on individual patient characteristics and the evolving landscape of treatment options. This research underscores the importance of a collaborative approach to cancer care, involving healthcare professionals and patients in developing personalized treatment plans.
Dr. Camel's Conclusion
The journey through cancer treatment is often marked by a series of challenges and uncertainties. This review provides a comprehensive overview of novel treatment options for platinum-sensitive recurrent ovarian cancer, highlighting the significant advancements in targeted therapies and the increasing focus on personalized treatment approaches. Just as a camel adapts to the changing terrain of the desert, healthcare professionals must be adaptable and innovative in their approach to cancer care, ensuring that patients receive the most effective and personalized treatment strategies.
Date :
- Date Completed 2019-02-21
- Date Revised 2019-02-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.